Literature DB >> 21813829

Three kidneys, two diseases, one antibody?

Nolwenn Lorcy1, Nathalie Rioux-Leclercq, Marie-Laure Lombard, Patrick Le Pogamp, Cécile Vigneau.   

Abstract

Anti-factor H antibody has been recently described as responsible for thrombotic microangiopathies (TMA) as well as membranoproliferative glomerulonephritis (MPGN). We report here, for the first time, the case of a woman with an anti-factor H antibody, who developed MPGN on native kidney, rapid recurrence on first graft, and TMA on second graft despite immunosuppressive therapy and plasma exchanges. This case supports the hypothesis that MPGN and TMA are closely linked by common pathogenic mechanisms and the need for complete exploration of complement pathway including factor H activity and autoantibody in front of any MPGN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813829     DOI: 10.1093/ndt/gfr436

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  21 in total

1.  Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.

Authors:  Elisa Gnappi; Marco Allinovi; Augusto Vaglio; Elena Bresin; Annalisa Sorosina; Francesco P Pilato; Landino Allegri; Lucio Manenti
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

Review 2.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

3.  Circulating complement levels and C3 glomerulopathy.

Authors:  Fernando C Fervenza; Sanjeev Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-23       Impact factor: 8.237

Review 4.  Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Authors:  Marina Noris; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2018-06-09       Impact factor: 3.714

Review 5.  Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.

Authors:  Andrew S Bomback; Gerald B Appel
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

6.  Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.

Authors:  Katherine A Vernon; Marieta M Ruseva; H Terence Cook; Marina Botto; Talat H Malik; Matthew C Pickering
Journal:  J Am Soc Nephrol       Date:  2015-09-15       Impact factor: 10.121

Review 7.  Making sense of the spectrum of glomerular disease associated with complement dysregulation.

Authors:  Sally Ann Johnson; Edwin K S Wong; C Mark Taylor
Journal:  Pediatr Nephrol       Date:  2013-07-14       Impact factor: 3.714

Review 8.  Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

Authors:  An S De Vriese; Sanjeev Sethi; Jens Van Praet; Karl A Nath; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 10.121

Review 9.  Anti-complement-factor H-associated glomerulopathies.

Authors:  Marie-Agnes Dragon Durey; Aditi Sinha; Shambhuprasad Kotresh Togarsimalemath; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

10.  Factors influencing treatment of atypical hemolytic uremic syndrome.

Authors:  Carla M Nester; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-18       Impact factor: 10.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.